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Internal endoconduit: An innovative technique
to address unfavorable iliac artery anatomy
encountered during thoracic endovascular
aortic repair
Brian G. Peterson, MD,a and Jon S. Matsumura, MD,b Saint Louis, Mo; and Chicago, Ill
Various strategies have been used to combat arterial access limitations encountered during thoracic endovascular aortic
repair (TEVAR).Most require retroperitoneal dissection or aggressive angioplasty techniques that can lead to devastating
complications. We describe a novel technique using an “internal endoconduit.” Deployment of an iliac stent graft across
the prohibitively stenotic area, followed by angioplasty and controlled rupture of the iliac artery, allows for safe passage
of the delivery sheath. Adverse events associated with decreased pelvic perfusion or hemorrhage from iliac artery rupture
are theoretically possible but have not been observed. Faced with unfavorable iliac anatomy, we use internal endoconduits
rather than retroperitoneal access procedures and believe their use will increase the number of procedures that will be able
to be performed through femoral access and substantially reduce the frequency of access-related complications. ( J Vasc
Surg 2008;47:441-5.)Remote arterial access limitations and access complica-
tions have been addressed by various strategies since the
introduction of thoracic endovascular aortic repair
(TEVAR). Often the presence of iliac artery tortuosity,
occlusive disease, and small caliber require adjunctive mea-
sures to proceed with TEVAR. These techniques include
the use of conduits, direct aortoiliac access, and various
forms of angioplasty. We describe a method for dealing
with unfavorable iliac artery anatomy by reporting a case in
which an internal endoconduit and controlled iliac artery
rupture were used to overcome access limitations in the
setting of percutaneous TEVAR for a ruptured thoracic
aortic aneurysm.
CASE REPORT
Percutaneous, internal endoconduit for TEVAR was used in a
75-year-old man with a known descending thoracic aortic aneu-
rysm, bilateral critical ischemia with forefoot dry gangrene, recent
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doi:10.1016/j.jvs.2007.07.061contrast nephrotoxicity, and biliary sepsis who presented with
acute back pain. On examination, he had significant epigastric
discomfort and had weakly palpable femoral pulses bilaterally.
An initial noncontrast computed tomography (CT) scan dem-
onstrated rapid interval aneurysm growth, and high-density,
crescent-shaped material within the aneurysm sac suggesting po-
tential instability. The aneurysm, which was confined to the de-
scending thoracic aorta, had a maximal diameter of 6.2 cm, a
proximal neck diameter of 35 mm, and distal neck diameter of 32
mm. A stent had been recently placed in the right iliofemoral
artery, and the left external iliac artery had circumferential calcified
narrowing.
The patient was treated for biliary sepsis, and renal function
was improving when he experienced an acute exacerbation of his
back pain. He was prepared immediately for intervention, but
because he was deemed an unsuitable candidate for open repair, an
attempt at TEVAR was undertaken.
A standard anterior wall, common femoral artery puncture was
performed with the assistance of ultrasound imaging and con-
firmed angiographically. A marker catheter was advanced into the
abdominal aorta, and a diagnostic aortogram was obtained using
gadolinium. He was noted to have widely patent, nonaneurysmal
common iliac arteries, an occluded left hypogastric artery, and
diffusely diseased external iliac arteries bilaterally. The assessment
was made that the combination of recent contralateral stenting,
heavy calcification, and diffuse disease in these arteries would
preclude the passage of the 24F sheath needed for delivery of the
stent graft without an adjunctive intervention or access other than
the common femoral artery (Fig 1).
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from the relatively disease-free portion of the distal common iliac
artery and extending into the proximal common femoral artery
through the diseased external iliac artery to allow passage of the
24F delivery sheath. After deployment of a 10F suture-mediated
closure device (Prostar XL, Abbott, Menlo Park, Calif) in the
standard “preclose” fashion, a 14-cm-long stent graft with a
16-mmproximal diameter 12-mmdistal diameter (W.L. Gore&
Assoc, Flagstaff, Ariz), designed for use during infrarenal aortic
aneurysm repair as a contralateral limb, was deployed from the
common iliac extending into the proximal common femoral artery.
The prosthesis was initially dilated with a noncompliant
10-mm balloon creating a controlled rupture of the external iliac
artery with proximal seal in the common iliac artery and distal seal
in the common femoral artery, but this did not allow passage of the
24F sheath. Balloon angioplasty was therefore repeated with a
12-mm balloon, and this allowed successful passage of the 24F
sheath (Fig 2 and 3).
A descending thoracic aortogram demonstrated a ruptured
thoracic aortic aneurysm, with active extravasation of contrast,
about 4 cm above the celiac artery origin (Fig 4, A). A 40-mm 
10-cm TAG thoracic endoprosthesis (W. L. Gore & Assoc) was
then deployed in standard fashion, and a completion angiogram
demonstrated exclusion of the aneurysm and site of rupture from
the circulation (Fig 4, B).
The 24F sheath was partially withdrawn, and an angiogram
Fig 3. Delivery sheath (24F) is shown passing through the inter-
nal endoconduit after ballooning with 12-mm noncompliant bal-
loon.Fig 2. Angioplasty of the proximal seal zone with a 12-mmFig 1. Left iliac arteriogram demonstrates the diffusely diseased
external iliac artery with the internal endoconduit in place beforeobtained through the sheath demonstrated complete seal of the
area
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extravasation. The 24F sheath was removed and the “preclose”
sutures were tied obtaining hemostasis.
The patient remained hemodynamically stable throughout the
operative procedure. A normal femoral pulse was present upon
completion of the procedure, and the patient was neurologically
intact. He remained neurologically intact throughout his hospital
stay and was free from buttock claudication, colon ischemia, or
other adverse sequelae of impaired pelvic perfusion. Follow-up was
limited in this patient because he died 2 months after the proce-
dure. An autopsy was not performed.
Two subsequent instances in which unfavorable iliac artery
anatomy has been encountered in the setting of TEVAR and
EVAR have been dealt with similarly using internal endoconduits
and have been successful in allowing passage of the delivery sheath,
providing seal for the controlled iliac artery rupture, and being free
from the complications of decreased pelvic circulation. Patients
have been followed up clinically and radiographically with CT
scans at 1 month and every 6 months for the first year. There have
been no late complications related to decreased pelvic perfusion or
iliac artery hemorrhage.
DISCUSSION
Extensive iliac artery calcification and occlusive disease
often precludes femoral access for TEVAR. In an interna-
tional survey of thoracic aortic stent graft experience, pri-
mary access other than the common femoral artery was
required in approximately 15% of TEVAR cases.1 This is
similar to the 15% incidence of iliac conduit use in the phase
II, multicenter trial of the only thoracic endoprosthesis
Fig 4. A, Thoracic aortogram demonstrates active extra
endovascular aortic repair demonstrates exclusion of theapproved by United States Food and Drug Administration(FDA).2 In this study, the three failures of deployment
were directly related to access issues due to unfavorable iliac
artery anatomy, and the largest group of early major adverse
events in this trial were access-related complications.
Retroperitoneal dissection and placement of a pros-
thetic iliac conduit is the most commonly used option to
combat iliac disease. As an alternative, retroperitoneal ex-
posure, followed by direct aorta or iliac artery access, can be
used during TEVAR, thus avoiding the use of prosthetic
conduit and eliminating the need for more extensive retro-
peritoneal dissection.3,4 Retroperitoneal dissection ac-
counts for a significant portion of the morbidity risk of
TEVAR, and this has been well described when retroperi-
toneal procedures are used in conjunction with endovascu-
lar abdominal aortic aneurysm repair.5 In this study, Lee et
al5 found a 2.6-fold greater blood loss, 82% longer proce-
dure time, 1.5-day longer hospital length of stay, and
1.8-fold higher rate of perioperative complications when
retroperitoneal procedures were performed rather than
standard femoral exposure.
The added morbidity of retroperitoneal procedures has
been recognized and has led to the development of inge-
nious adjunctive measures to allow for femoral access when
iliac disease would otherwise preclude this route of access.
In situ introducer sheath dilatation described by von Se-
gesser et al6 involves balloon dilatation within smaller cali-
ber sheaths than what would normally be required for
device delivery. In their description of this technique, bal-
loon dilatation with an 8-mm balloon inside an 18F sheath
can allow passage of a device that would typically require a
ion of contrast. B, Completion aortogram after thoracic
of extravasation from the circulation.vasat24F sheath.
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luminal angioplasty of the iliac arteries7 or serial dilatation
of the iliacs with hydrophilic dilators often allow passage of
delivery sheaths used during TEVAR, but aggressive angio-
plasty is often needed for these large sheaths to pass, which
can lead to iliac artery dissection, or more worrisome,
uncontrolled iliac artery rupture.
Efforts to protect against these devastating complica-
tions led to the development of the endoluminal iliofemo-
ral bypass conduit by Yano et al.8 In this technique, a stent
is sutured to a prosthetic conduit and backloaded into a
sheath for delivery of the stent across the internal iliac artery
and extension of the prosthetic across the external iliac
artery. A noncompliant balloon is then used to dilate the
external iliac artery from within the prosthetic graft, and
when the endovascular portion of the procedure is com-
pleted, the conduit is sewn to the external iliac artery or an
endoluminal anastomosis is made to the common femoral
artery. Similar to their technique, the internal endoconduit
allows femoral access for TEVAR when the patient has
severe iliac occlusive disease.
Unlike prosthetic iliac conduits or direct aortoiliac ac-
cess procedures, the morbidity associated with retroperito-
neal dissection is avoided by using internal endoconduits.
Angioplasty similarly allows for femoral access without
retroperitoneal procedures, but iliac artery rupture associ-
ated with angioplasty is the most common life-threatening
complication associated with TEVAR. Internal endocon-
duits allow for the same aggressive iliac angioplasty as seen
with in situ introducer sheath dilatation and endoluminal
conduits, but this is performed in a more controlled fash-
ion. Once adequate proximal and distal seal with the inter-
nal endoconduits is established, aggressive angioplasty can
be initiated in the lesions with theoretically less concern for
life-threatening hemorrhage from vessel rupture. This pre-
emptive strategy of controlled iliac rupture avoids the need
for emergency endovascular or open repair, when faced
with iliac rupture, using other adjunctive techniques for
femoral access in the setting of TEVAR.
As seen in the case presented, passage of a 24F sheath
through a 12-mm iliac limb requires angioplasty with a
noncompliant 12-mm balloon. Subsequent use of the in-
ternal endoconduit technique has taught us that passage of
a 20F or 22F sheath through the endoconduit can be
accomplished with 10-mm balloon angioplasty. The Table
summarizes these approximate sizing requirements and
incorporates other guidelines obtained from the device’s
instructions for use. The balloon sizes are based on the
initial limited experience of unsuccessfully trying smaller
sized balloons.
One of the major concerns with the use of internal
endoconduits is that the hypogastric artery origin is often
not spared. Although complications of decreased pelvic
perfusion such as paraplegia, gluteal necrosis, and buttock
claudication are theoretic concerns and have been reported
to occur in up to 40% of patients with acute coverage or coil
embolization of patent hypogastric arteries,9 these prob-
lems were not observed in this series. When possible, pa-tency of the inferior epigastric and superficial circumflex
iliac arteries should be maintained in an effort to optimize
pelvic perfusion through collateral circulation, although
one of these branches was sacrificed in this patient because
the occlusive disease extended into the common femoral
artery.
Mell et al10 demonstrated similar tolerance to hypogas-
tric artery coverage in the setting of endovascular aortoiliac
or iliac artery aneurysm repair. Perhaps this can be ex-
plained by the fact that only the origin of the hypogastric
artery is covered and collateral pelvic circulation is main-
tained. Nevertheless, in the setting of TEVAR where para-
plegia concerns are amplified, the relative risks of hypogas-
tric artery coverage, retroperitoneal dissection, and
hypotension from iliac artery rupture should be carefully
considered. Larger series need to be examined before any
conclusions can be made about the safety of this technique.
Until thoracic endoprostheses used in TEVAR are
available in lower profile designs, the off-label use of iliac
stent-grafts as internal endoconduits avoids the complica-
tions associated with retroperitoneal dissections and allows
most TEVAR cases to be performed with femoral access.
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